FFA
JAZZ icon

Farther Finance Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Farther Finance Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
1,563
+990
+173% +$217K ﹤0.01% 1763
2026
Q1 		$108K Sell
573
-84
-13% -$14.7K ﹤0.01% 2457
2025
Q4 		$112K Buy
657
+392
+148% +$60.1K ﹤0.01% 2274
2025
Q3 		$34.9K Buy
265
+234
+755% +$28.1K ﹤0.01% 2670
2025
Q2 		$3.29K Sell
31
-49
-61% -$5.32K ﹤0.01% 3526
2025
Q1 		$10K Sell
80
-40
-33% -$5.22K ﹤0.01% 2734
2024
Q4 		$14.8K Buy
120
+51
+74% +$6.01K ﹤0.01% 2216
2024
Q3 		$7.69K Sell
69
-4
-5% -$438 ﹤0.01% 2469
2024
Q2 		$7.77K Buy
73
+53
+265% +$5.83K ﹤0.01% 2177
2024
Q1 		$2.38K Sell
20
-27
-57% -$3.31K ﹤0.01% 2416
2023
Q4 		$5.78K Buy
47
+10
+27% +$1.25K ﹤0.01% 1891
2023
Q3 		$4.79K Buy
37
+8
+28% +$1.07K ﹤0.01% 1530
2023
Q2 		$3.6K Buy
29
+3
+12% +$404 ﹤0.01% 1549
2023
Q1 		$3.81K Buy
26
+2
+8% +$296 ﹤0.01% 1423
2022
Q4 		$3.82K Buy
+24
New +$3.52K ﹤0.01% 1258

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Farther Finance Advisors's JAZZ Position: Q2 2026 in Review

Farther Finance Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 173% in Q2 2026, buying an estimated $217K and bringing the position to 1,563 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Farther Finance Advisors first reported a position in JAZZ in Q4 2022 and has held it in 15 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Farther Finance Advisors held 1,563 shares of Jazz Pharmaceuticals worth $376K as of Q2 2026.
  • Farther Finance Advisors bought 990 Jazz Pharmaceuticals shares in Q2 2026, an estimated $217K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1763 holding.
  • Farther Finance Advisors first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.